Liver transplantation: indications and results

被引:20
作者
Strassburg, C. P. [1 ]
Manns, M. P. [1 ]
机构
[1] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, D-30625 Hannover, Germany
来源
INTERNIST | 2009年 / 50卷 / 05期
关键词
Model for end stage liver disease; Liver cirrhosis; Allocation; Hepatocellular carcinoma; Liver transplantation; QUALITY-OF-LIFE; DISEASE MELD; WAITING-LIST; HEPATITIS-B; MODEL; SURVIVAL; ALLOCATION; IMPACT; SCORE; TERM;
D O I
10.1007/s00108-008-2268-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
After around 64 000 transplantations in Europe since 1988 liver transplantation has emerged as a standard treatment option for otherwise incurable chronic liver diseases. Cirrhosis of different etiologies represents the most frequent transplant indication. Overall survival in this group amounts to 72% after 5 years, and 62% after 10 years. In Germany, the main indications include alcoholic liver cirrhosis, tumors with increasing numbers in recent years, as well as viral diseases leading to cirrhosis. Since December 2006 the priority for liver transplantation is determined by the model for end stage liver disease (MELD) and not by the length of waiting time. MELD is a statistical model based on serum creatinine, serum bilirubin and coagulation, which describes the probability of 3-month mortality of a potential transplant candidate. Not all liver diseases are adequately represented by MELD necessitating the additional use of a defined number of standard exceptions that have been last updated in 2008. As a consequence of these developments indications, selection of recipients and the management of the waiting list have seen profound change.
引用
收藏
页码:550 / 560
页数:11
相关论文
共 34 条
[1]   Impact of the MELD score on waiting time and disease severity in liver transplantation in united states veterans [J].
Ahmad, Jawad ;
Downey, Kathy K. ;
Akoad, Mohamed ;
Cacciarelli, Thomas V. .
LIVER TRANSPLANTATION, 2007, 13 (11) :1564-1569
[2]   Model for end-stage liver disease - Did the new liver allocation policy affect waiting list mortality? [J].
Austin, Mary T. ;
Poulose, Benjamin K. ;
Ray, Wayne A. ;
Arbogast, Patrick G. ;
Feurer, Irene D. ;
Pinson, Wright .
ARCHIVES OF SURGERY, 2007, 142 (11) :1079-1085
[3]   Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients [J].
Berenguer, M ;
Prieto, M ;
San Juan, F ;
Rayón, JM ;
Martinez, F ;
Carrasco, D ;
Moya, A ;
Orbis, F ;
Mir, J ;
Berenguer, J .
HEPATOLOGY, 2002, 36 (01) :202-210
[4]   3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome [J].
Burroughs, AK ;
Sabin, CA ;
Rolles, K ;
Delvart, V ;
Karam, V ;
Buckels, J ;
O'Grady, JG ;
Castaing, D ;
Klempnauer, J ;
Jamieson, N ;
Neuhaus, P ;
Lerut, J ;
de Goyet, JD ;
Pollard, S ;
Salizzoni, M ;
Rogiers, X ;
Muhlbacher, F ;
Valdecasas, JCG ;
Broelsch, C ;
Jaeck, D ;
Berenguer, J ;
Gonzalez, EM ;
Adam, R .
LANCET, 2006, 367 (9506) :225-232
[5]   A systematic review of the performance of the Model for End-Stage Liver Disease (MELD) in the setting of liver transplantation [J].
Cholongitas, Evangelos ;
Marelli, Laura ;
Shusang, Vibhakorn ;
Senzolo, Marco ;
Rolles, Keith ;
Patch, David ;
Burroughs, Andrew K. .
LIVER TRANSPLANTATION, 2006, 12 (07) :1049-1061
[6]  
Ciesek S, 2006, INTERNIST, V47, P252, DOI 10.1007/s00108-006-1583-1
[7]   Impact of dialysis and older age on survival after liver transplantation [J].
Dellon, E. S. ;
Galanko, J. A. ;
Medapalli, R. K. ;
Russo, M. W. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (09) :2183-2190
[8]   Model for end-stage liver disease (MELD) for liver allocation: A 5-year score card [J].
Freeman, Richard B., Jr. .
HEPATOLOGY, 2008, 47 (03) :1052-1057
[9]   Indications for and outcomes after combined lung and liver transplantation: A single-center experience on 13 consecutive cases [J].
Grannas, Gerrit ;
Neipp, Michael ;
Hoeper, Marius M. ;
Gottlieb, Jens ;
Lueck, Rainer ;
Becker, Thomas ;
Simon, Andre ;
Strassburg, Christian P. ;
Manns, Michael P. ;
Welte, Tobias ;
Haverich, Axel ;
Klempnauer, Juergen ;
Nashan, Bjoern ;
Strueber, Martin .
TRANSPLANTATION, 2008, 85 (04) :524-531
[10]   Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients [J].
Greten, TF ;
Papendorf, F ;
Bleck, JS ;
Kirchhoff, T ;
Wohlberedt, T ;
Kubicka, S ;
Klempnauer, J ;
Galanski, M ;
Manns, MP .
BRITISH JOURNAL OF CANCER, 2005, 92 (10) :1862-1868